Levadura Biotechnology Enters US Cannabis Market
Cannabis use is growing mainstream whether for recreational purposes or pharmaceutical; more and more people are finding a way to incorporate cannabis into their lifestyles. Not everyone will want to use products like dry cannabis or cannabis oil and will turn instead to convenient and familiar products containing the cannabinoids they seek. For this reason, many companies are entering the cannabinoid biosynthesis market, Levadura Biotechnology now included.
Levadura had their first patent application (US Pub. No. 20200224231) published for a way to produce cannabinoids using engineered yeast and fatty acids. There are now over 80 patent filings in the US related to the synthesis of cannabinoids and over 25 companies with ownership. Learn more about them with a subscription to Magic Number’s Cannabis Patent Forecast®.
Related Posts
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…